Use of Cytomegalovirus-Specific Hyperimmunoglobulins in Pregnancy: A Retrospective Cohort

Journal of Obstetrics and Gynaecology Canada

Volumn 40, Issue 11, 2018, Pages 1409-1416

  Minsart, Anne Frédérique ^a   Smiljkovic, Mina ^a   Renaud, Christian ^a   Gagné, Marie Pierre ^a   Lamarre, Valérie ^a   Kakkar, Fatima ^a   Boucher, Marc ^a   Boucoiran, Isabelle ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

congenital; Cytomegalovirus; cytomegalovirus specific hyperimmune globulin; immunoglobulins; pregnancy

Indexed keywords

CYTOMEGALOVIRUS SPECIFIC HYPERIMMUNOGLOBULIN; HYPERIMMUNE GLOBULIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN; VIRUS ANTIBODY;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MATERNAL DISEASE; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIMARY INFECTION; QUEBEC; RETROSPECTIVE STUDY; PREGNANCY; PREGNANCY COMPLICATION;

AMNIOCENTESIS; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 85048754763     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jogc.2018.03.013     Document Type: Article

References (23)

1. Wang, C., Zhang, X., Bialek, S., et al. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 52 (2011), e11–e13.
2. Cannon, M.J., Schmid, D.S., Hyde, T.B., Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20 (2010), 202–213.
3. Lamarre, V., Gilbert, N.L., Rousseau, C., et al. Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Quebec, 2010–2013. Epidemiol Infect 144 (2016), 1701–1709.
4. Manicklal, S., Emery, V.C., Lazzarotto, T., et al. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26 (2013), 86–102.
5. Yamamoto, A.Y., Mussi-Pinhata, M.M., Boppana, S.B., et al. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol, 202, 2010, 297 e1–8.
6. Evans, C., Brooks, A., Anumba, D., et al. Dilemmas regarding the use of CMV-specific immunoglobulin in pregnancy. J Clin Virol 57 (2013), 95–97.
7. Leruez-Ville, M., Ville, T., Optimum treatment of congenital cytomegalovirus infection. Expert Rev Anti Infect Ther 14 (2016), 479–488.
8. Japanese Congenital Cytomegalovirus Infection Immunoglobulin Fetal Therapy Study Group. A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection. J Reprod Immunol 95 (2012), 73–79.
9. Visentin, S., Manara, R., Milanese, L., et al. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis 55 (2012), 497–503.
10. Nigro, G., Adler, S.P., La Torre, R., et al. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353 (2005), 1350–1362.
11. Nigro, G., Adler, S.P., Gatta, E., et al. Fetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy. J Matern Fetal Neonatal Med 25 (2012), 2202–2205.
12. Nigro, G., Adler, S.P., Parruti, G., et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy: a case-control study of the outcome in children. J Infect Dis 205 (2012), 215–227.
13. Buxmann, H., Stackelberg, O.M., Schlosser, R.L., et al. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 40 (2012), 439–446.
14. Wagner, N., Kagan, K.O., Haen, S., et al. Effective management and intrauterine treatment of congenital cytomegalovirus infection: review article and case series. J Matern Fetal Neonatal Med 27 (2014), 209–214.
15. Revello, M.G., Lazzarotto, T., Guerra, B., et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 370 (2014), 1316–1326.
16. Hamilton, S.T., van Zuylen, W., Shand, A., et al. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev Med Virol 24 (2014), 420–433.
17. Moxley, K., Knudtson, E.J., Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol 111 (2008), 524–526.
18. Yinon, Y., Farine, D., Yudin, M.H., Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv 65 (2010), 736–743.
19. Society for Maternal-Fetal Medicine, Hughes, B.L., Gyamfi-Bannerman, C., Diagnosis and antenatal management of congenital cytomegalovirus infection. Am J Obstet Gynecol 214 (2016), B5–11.
20. Gunkel, J., Nijman, J., Verboon-Maciolek, M.A., et al. International opinions and national surveillance suggest insufficient consensus regarding the recognition and management practices of infants with congenital cytomegalovirus infections. Acta Paediatr 106 (2017), 1493–1498.
21. Harris, P.A., Taylor, R., Thielke, R., et al. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42 (2009), 377–381.
22. Juckstock, J., Rothenburger, M., Friese, K., et al. Passive immunization against congenital cytomegalovirus infection: current state of knowledge. Pharmacology 95 (2015), 209–217.
23. Blazquez-Gamero, D., Galindo Izquierdo, A., Del Rosal, T., et al. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid [e-pub ahead of print]. J Matern Fetal Neonatal Med, 2017, 10.1080/14767058.2017.1387890 Accessed March 23, 2018.